Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; the new revision notice shows Revision: v3.4.2 and replaces the previous Revision: v3.4.1.SummaryDifference0.0%

- Check20 days agoChange DetectedFooter/site revision updated from v3.4.0 to v3.4.1; no changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary feature added; page metadata labels updated (Last Update Submitted that Met QC Criteria and No FEAR Act Data); revision bumped to v3.4.0. These are UI/metadata refinements and do not alter core study information, eligibility criteria, endpoints, or results.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed as part of a backend update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdds an extensive, international list of enrollment locations across the US, Australia, and other regions, detailing cities and regions where the trial is conducted. This clarifies the geographic scope for recruitment and helps potential participants find eligible sites.SummaryDifference3%

- Check91 days agoChange DetectedThe PubMed publications note was updated to indicate publications are automatically filled from PubMed. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.